Zhang, L., Taboada, L. A., Baglamis, S., Kroon, M. d., Elshout, C., Ramesh, P., . . . Medema, J. P. GSK-3 and BCL-XL inhibition mitigates the competitive advantage of APC-mutant colorectal cancer cells. Nature Publishing Group.
Chicago Style (17th ed.) CitationZhang, Le, et al. GSK-3 and BCL-XL Inhibition Mitigates the Competitive Advantage of APC-mutant Colorectal Cancer Cells. Nature Publishing Group.
MLA (9th ed.) CitationZhang, Le, et al. GSK-3 and BCL-XL Inhibition Mitigates the Competitive Advantage of APC-mutant Colorectal Cancer Cells. Nature Publishing Group.
Warning: These citations may not always be 100% accurate.